Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OctreoScan in Geriatric and Renal Impairment Patients
NCT00944372Phase 4Terminated
- Sponsor
- Mallinckrodt Pharmaceuticals
- Start
- Jul 2003
- Primary completion
- Aug 2005
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of indium-111 pentetreotide in solid tumor, sponsored by Mallinckrodt Pharmaceuticals. Started Jul 2003; status: terminated.
02
Drugs
indium-111 pentetreotide
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00944372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944372.